Search results
About Avellino Avellino Lab USA, Inc. is a global leader in genetic molecular diagnostics at the forefront of precision medicine for eye care. With a long-term mission to develop personalized approaches to
Eric joins Avellino Labs from Alcon, bringing 20 years of product development and commercialization experience in the ophthalmic surgical industry. Eric started his career in patient care and moved into the industry in 1999 with Summit Technology, one of the first excimer laser manufacturers.
This quarter, the company begins rolling out the availability of AvaGen in a controlled launch leading to nationwide availability of the genetic diagnostic in 2020. AvaGen is the first commercially available genetic diagnostic test of its kind for keratoconus and corneal dystrophies.
Oct 4, 2021 · Avellino is acting to make workplace and patient care safety a reality for everyone. That’s why we created Avellino ACTS Safety Program to provide testing and communication tools to help you keep the people you are responsible for safe and confident that your organization is committed to safety. THE AVELLINO A.C.T.S. PROGRAM
Why Avellino Lab Universal Test? 100% in sensitivity, specificity, and reliability. Clinically shown via a large clinical trials in Korea related to corneal dystrophy. 5
eric.bernabei@avellino.com. AVELLINO INTRODUCES NEW MULTIPLEX RESPIRATORY PANEL . Simultaneous detection of COVID-19 and influenza viruse s . MENLO PARK, CALIFORNIA (November 9, 2020) — Avellino announced today that the company has developed a novel multi-panel RT-PCR-based virus assay, AvellinoCoV2-Respiratory, which
1505 Adams Drive, Suite B2. Menlo Park, CA 94025. Home. Company
Stanley Chang has developed and operated numerous business organizations located in multiple countries. Prior to joining Avellino, he was the founding attorney of Perspectives Law Group.
Dec 15, 2020 · MENLO PARK, CALIFORNIA (December 15, 2020) — Avellino announced today the appointment of three new members to its Board of Directors. In addition, the company announced a new Chief Executive Officer and President, and Chief Financial Officer and Treasurer. All appointments are effective December 2020.
Susan (Siw) Daniels is Avellino’s Chief Scientific Officer, bringing more than 25 years of experience developing molecular disease technology and diagnostics solutions.
